FERROUS SULFATE- ferrous sulfate tablet 
Richmond Pharmaceuticals Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Ferrous Sulfate Tablets 325 mg (5 gr)

SAVE CARTON FOR COMPLETE PRODUCT INFORMATION

Supplement Facts
% Daily Value
Iron (as ferrous sulfate) 65 mg360%

SUGGESTED USE: 

Adults: One (1) tablet daily, preferably after meals or as directed by the doctor.

Children: As directed by the doctor.

EACH TABLET CONTAINS:                                                                  % U.S. RDA*

Elemental Iron 65 mg (Equivalent to 325 mg of Ferrous Sulfate)                        60

*U.S. Recommended Daily Allowance

INACTIVE INGREDIENTS:

croscarmellose sodium, dicalcium phosphate, FD&C red #40 (Al-lake), FD&C yellow #6 (Al-lake), hypromellose, magnesium stearate, microcrystalline cellulose, PEG 400, titanium dioxide

WARNING:  Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.

WARNINGS:

Do not exceed recommended dosage. The treatment of any anemic condition should be under the advice and supervision of a doctor. Occasional gastrointestinal discomfort (such as nausea) may be minimized by taking with meals. Iron-containing medication may occasionally cause constipation or diarrhea.

As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

DRUG INTERACTION PRECAUTION: Since oral iron products interfere with absorption of oral tetracycline antibiotics, these products should not be taken within two hours of each other.

OTHER INFORMATION:

Each tablet contains: calcium 20 mg (2% Daily value)

Store in a dry place at controlled room temperature at 15°-30°C (59°-86°F).

Do not expose to excessive heat or moisture.

QUESTIONS OR COMMENTS?

call 804-270-4498, 8:30 am - 4:30 pm ET, Monday – Friday

TAMPER EVIDENT: DO NOT USE IF A BLISTER PACKAGE UNIT IS TORN, BROKEN OR SHOW ANY SIGN OF TAMPERING

*Richmond Pharmaceuticals, Inc. is not affiliated with the owner of the registered trademark FEOSOL®.

Distributed by: Richmond Pharmaceuticals, Inc., Richmond, VA 23233, USA

CR1210

Principle Display Panel

NDC 54738-963-13

Compare to Active Ingredient in Feosol ®*

Ferrous Sulfate Tablets
325 mg (5 gr)

Red

Iron Supplement
100 Tablets (25x4) UNIT DOSE

Richmond Pharmaceuticals, Inc.
Richmond, VA 23233

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

39803ffc-figure-01
FERROUS SULFATE 
ferrous sulfate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54738-963
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
FERROUS SULFATE (UNII: 39R4TAN1VT) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION325 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorredScoreno score
ShapeROUNDSize8mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:54738-963-13100 in 1 BOTTLE; Type 0: Not a Combination Product11/05/2008
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other11/05/2008
Labeler - Richmond Pharmaceuticals Inc. (043569607)
Establishment
NameAddressID/FEIBusiness Operations
Advance Pharmaceutical Inc.078301063manufacture(54738-963)

Revised: 12/2019
Document Id: 9a63ba0a-0df9-744b-e053-2a95a90a9344
Set id: 5514d582-19b5-4f1e-b794-f790afb8211c
Version: 2
Effective Time: 20191223
 
Richmond Pharmaceuticals Inc.